Ajanta Pharma Limited
1,490words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
60%
ing with growth exceeding industry average 2nd largest in India, surpassing segment growth by 60% Growth becomes reality, exceeding segment growth Jumped 2 ranks with excellent growth perfor
23%
IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 23% 14% 16% 9% 6% 6% 16% 16% 11% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Sourc
14%
Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 23% 14% 16% 9% 6% 6% 16% 16% 11% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IM
16%
a Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 23% 14% 16% 9% 6% 6% 16% 16% 11% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS MAT
9%
rma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 23% 14% 16% 9% 6% 6% 16% 16% 11% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS MAT, Ju
6%
IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 23% 14% 16% 9% 6% 6% 16% 16% 11% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS MAT, June 2
11%
a IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 23% 14% 16% 9% 6% 6% 16% 16% 11% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS MAT, June 2019 6 of 26 Segme
10%
M Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 23% 14% 16% 9% 6% 6% 16% 16% 11% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS MAT, June 2019 6 of 26 Segment Gr
18%
a Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 16% 16% 18% 10% 10% 12% 13% 11% 18% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS
12%
Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 16% 16% 18% 10% 10% 12% 13% 11% 18% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS MAT, June 2019
13%
a Pharma IPM Ajanta Pharma IPM Ajanta Pharma IPM Ajanta Pharma 16% 16% 18% 10% 10% 12% 13% 11% 18% 10% 31st July 2019 IPM = Indian Pharmaceutical Market Source: IMS MAT, June 2019 7 of
30%
ndia Sales India Sales – Q1 (Rs. cr.) 9% 194 178 Q1 FY19 Q1 FY20 IMS MAT June 2019 Ophthal 30% Cardio 42% Pain 6% Derma 22% IMS MAT June 2018 Ophthal 30% Cardio 41% Pain 6% Derma 23% 31
Advertisement